Gene Biotherapeutics Competitors and Similar CompaniesClear all
Gene Biotherapeutics's competitors and similar companies include Resverlogix, Strategic Partners, Benitec Biopharma and Periphagen.
 Gene Biotherapeutics Gene Biotherapeutics (formerly known as Taxus Cardium Pharmaceuticals and Cardium Therapeutics) is a company that manages a portfolio of medical technologies. |  Resverlogix Resverlogix is a clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses. |  Strategic Partners Strategic Partners (formerly known as Orphazyme) is a company that forms partnerships with biotech, industrial, commercial, property, and asset management companies. |  Benitec Biopharma Benitec Biopharma is a biotechnology company developing a therapeutic platform that combines RNA interference with gene therapy. |  Periphagen Periphagen is a biopharmaceutical company focused on peripheral nerve gene therapy for disorders such as neuropathy and chronic pain. | |
Founding Date | Founding Date 2003 | Founding Date 2001 | Founding Date 2009 | Founding Date 2001 | Founding Date 2012 |
Type | Type Public | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Calgary, CA HQ San Francisco, US | Locations København, DK HQ Chicago, US Newton, US | Locations Hayward, US HQ Melbourne, AU Louisville, US | Locations Pittsburgh, US HQ |
Employees | Employees 6 | Employees 19 | Employees 1 | Employees 14 | Employees 5 |
Valuation ($) | Valuation ($) 6.5 k | Valuation ($) 12.9 m | Valuation ($) 6.8 m | Valuation ($) 192 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) kr309k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $50k (FY, 2025) | Gross profit kr309k (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($651.6k) (FY, 2020) | Net income ($7.8m) (FY, 2025) | Net income (kr859k) (FY, 2025) | Net income ($37.9m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 10m | Total funding raised $ 58.8m | Total funding raised $ 36.3m | Total funding raised $ 6.5m |
For sources of this data, please see the company profile
View Company Profiles
Resverlogix
HQ
Calgary, CA
Employees
19
Resverlogix is a clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses.
View companyStrategic Partners
HQ
København, DK
Employees
1
Strategic Partners (formerly known as Orphazyme) is a company that forms partnerships with biotech, industrial, commercial, property, and asset management companies.
View companyBenitec Biopharma
HQ
Hayward, US
Employees
14
Benitec Biopharma is a biotechnology company developing a therapeutic platform that combines RNA interference with gene therapy.
View companyPeriphagen
HQ
Pittsburgh, US
Employees
5
Periphagen is a biopharmaceutical company focused on peripheral nerve gene therapy for disorders such as neuropathy and chronic pain.
View company